Cramer Says Sell Teva Pharmaceutical, But Buy SunTrust Banks and These 2 Stocks
Jim Cramer made the following calls on May 9th, 2013. What do you think about his picks?
Teva Pharmaceutical Industries Limited (NYSE:TEVA): Jim Cramer ranked this stock a Sell. Cramer previously ranked this stock a Sell on April 11, 2013. The stock’s 52-week high is $42.83, and its 52-week low is $36.63. ”You are not going to get me involved with that one,” Cramer said. “It will have trouble with its drug rolling over, going off patent.”